{"abstract": "Rising Chinese demand for drugs is a boon for foreign companies, but bribery allegations against GlaxoSmithKline underscore the risk of scrutiny from officials.", "web_url": "https://www.nytimes.com/2013/07/17/business/global/for-drug-makers-china-becomes-a-perilous-market.html", "snippet": "Rising Chinese demand for drugs is a boon for foreign companies, but bribery allegations against GlaxoSmithKline underscore the risk of scrutiny from officials.", "lead_paragraph": "Multinational drug companies now employ more sales agents in China than they do in the United States, their largest market. Several, including Merck and GlaxoSmithKline, are making huge scientific investments in the country, including building research and development centers. Within the next few years, China is poised to surpass Japan as the world\u2019s second-largest pharmaceutical market.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2013/07/17/business/Drug-span/Drug-1374016413062-articleLarge.jpg", "height": 322, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2013/07/17/business/Drug-span/Drug-1374016413062-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 322}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2013/07/17/business/Drug-span/Drug-1374016413062-jumbo.jpg", "height": 549, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2013/07/17/business/Drug-span/Drug-1374016413062-superJumbo.jpg", "height": 1098, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2013/07/17/business/Drug-span/Drug-1374016413062-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2013/07/17/business/Drug-span/Drug-1374016413062-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2013/07/17/business/Drug-span/Drug-1374016413062-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "For Global Drug Manufacturers, China Becomes a Perilous Market", "kicker": null, "content_kicker": null, "print_headline": "For Global Drug Manufacturers, China Becomes a Perilous Market", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "persons", "value": "Thomas, Katie", "rank": 2, "major": "N"}, {"name": "glocations", "value": "China", "rank": 3, "major": "N"}, {"name": "organizations", "value": "GlaxoSmithKline PLC", "rank": 4, "major": "N"}], "pub_date": "2013-07-16T16:30:21+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": "Global Business", "byline": {"original": "By Katie Thomas", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/f25259ea-86fa-52ea-af59-da04b9780e2c", "word_count": 1221, "uri": "nyt://article/f25259ea-86fa-52ea-af59-da04b9780e2c"}